Indegene Ltd (INDGN) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Indegene reported Q3 FY25 revenue of 7,204 million, a 4.9% QoQ growth driven by earlier wins.
- EBITDA for Q3 FY25 reached 1,501 million, an 18.5% QoQ increase.
- Active clients increased from 68 to 75, with USD 1 million+ clients rising from 37 to 38.
- Revenue from top five accounts saw a 3.1% sequential growth.
- Five key deals (USD 2-4 million ACV each) secured with new and existing clients, expected to contribute revenue in upcoming quarters.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.